Executives On The Move: New CEO Appointed At La Jolla Pharmaceutical, COO Named At Mesoblast
Also, NeuBase Therapeutics has secured a new chief operating officer and Amgen has named a new vice president-finance/chief accounting officer.
You may also be interested in...
Ramp-up is possible thanks to increased internal capacity and network of voluntary licensing partners including Mylan, Cipla and Dr Reddy's.
New board directors named at Autolus Therapeutics, Beximco Pharmaceuticals, Tetraphase Pharmaceuticals and Vesigen.
The study is designed to support the regulatory approval process in China and confirm that the safety and immunogenicity profile observed in German and US trials is comparable to that of Chinese participants, according to BioNTech.